Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome

NCT04400045 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Nijmegen Breakage Syndrome

Interventions

DRUG: Treosulfan

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology